Cellular and molecular predictors of chronic renal dysfunction after initial ischemia/reperfusion injury of a single kidney

Transplantation

Volumn 64, Issue 2, 1997, Pages 190-197

  Azuma, Haruhito ^a,b,c   Nadeau, Kari ^a,d   Takada, Moriatsu ^a,b   Mackenzie, Harald S ^b   Tilney, Nicholas L ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c OSAKA MEDICAL COLLEGE   (Japan)

^d BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN; INTERCELLULAR ADHESION MOLECULE 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC DISEASE; GLOMERULOSCLEROSIS; GRAFT FAILURE; ISCHEMIA; KIDNEY ALLOGRAFT REJECTION; KIDNEY MASS; KIDNEY TRANSPLANTATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RAT; REPERFUSION INJURY;

ANIMALS; BODY WEIGHT; CHRONIC DISEASE; ENDOTHELINS; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; IMMUNOHISTOCHEMISTRY; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON TYPE II; INTERLEUKIN-1; INTERLEUKIN-6; KIDNEY; KIDNEY DISEASES; MALE; NEPHRECTOMY; ORGAN SIZE; PROTEINURIA; RATS; RATS, INBRED F344; RATS, INBRED LEW; REPERFUSION INJURY; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030816190     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199707270-00002     Document Type: Article

References (25)

1. Gjertson DW. Survival trends in long-term first cadaver-donor kidney transplants. In: Terasaki PI, Cecka JM, eds. Clinical transplants 1991. Los Angeles: UCLA Tissue Typing Laboratory, 1992: 225.
2. vanEs A, Hermans J, van Bockel JH, Persijn GG, vanHooff JP, deGraeff J. Effect of warm ischemia time and HLA (A and B) matching on renal cadaveric graft survival and rejection episodes. Transplantation 1983; 36: 255.
3. Sanfilippo F, Vaughn WK, Spees EK, Lucas BA. The detrimental effects of delayed graft function in cadaver donor renal transplantation. Transplantation 1984; 38: 643.
4. Halloran PF, Aprile MA, Farewell V, et al. Early function as the principal correlate of graft survival: a multivariate analysis of 200 cadaveric renal transplants treated with a protocol incorporating antilymphocyte globulin and cyclosporine. Transplantation 1988; 46: 223.
5. Najarian JS, Gillingham KJ, Sutherland DE, Reinsmoen NL, Payne WD, Matas AJ. The impact of the quality of initial graft function on cadaver kidney transplants. Transplantation 1994; 57: 812.
6. Tullius SG, Heemann UW, Hancock WW, Azuma H, Tilney NL. Long-term kidney isografts develop functional and morphologic changes that mimic those of chronic allograft rejection. Ann Surg 1994; 220: 425.
7. Hancock WH, Whitley WD, Tullius SG, et al. Cytokines, adhesion molecules, and the pathogenesis of chronic rejection of rat renal allografts. Transplantation 1993; 56: 643.
8. Cole E, Naimark D, Aprile M, et al. An analysis of predictors of long-term cadaveric renal allograft survival. Clin Transplant 1995; 9: 282.
9. Troppmann C, Gillingham KJ, Benedetti E, et al. Delayed graft function, acute rejection, and outcome after cadaver renal transplantation: a multivariate analysis. Transplantation 1995; 59: 962.
10. Goes N, Urmson J, Ramassar V, Halloran PF. Ischemic acute tubular necrosis induces an extensive local cytokine response: evidence for induction of interferon-γ, transforming growth factor-β1, granulocyte-macrophage colony-stimulating factor, interleukin-2, and interleukin-10. Transplantation 1995; 59: 565.
11. Mackenzie HS, Tullius SG, Heemann UW, et al. Nephron supply is a major determinant of long-term renal allograft outcome in rats. J Clin Invest 1994; 94: 2148.
12. Heemann UW, Azuma H, Tullius SG, Mackenzie H, Brenner BM, Tilney NL. The contribution of reduced functioning mass to chronic kidney allograft dysfunction in rats. Transplantation 1994; 58: 1317.
13. Mackenzie HS, Azuma H, Troy JL, Rennke HG, Tilney NL, Brenner BM. Augmenting kidney mass at transplantation abrogates chronic renal allograft injury in rats. Proc Assoc Am Phys 1996; 108: 128.
14. Azuma H, Nadeau K, Mackenzie HS, Brenner BM, Tilney NL. Nephron mass modulates the hemodynamic, cellular, and molecular response of the renal allograft in the rat. Transplantation 1997; 63: 519.
15. Brenner BM, Cohen RA, Milford EL. In renal transplantation, one size may not fit all. J Am Soc Nephrol 1992; 3: 162.
16. Bradley M, Schuman GB, Ward PCJ. Examination of urine. Henry JB, ed. Todd, Sanford, Davidsohn's clinical diagnosis and management by laboratory methods, 6th ed. Philadelphia: W.B. Saunders, 1979: 604.
17. Diamond JR, Tilney NL, Frey J, et al. Progressive albuminuna and glomerulosclerosis in a rat model of chronic renal allograft rejection. Transplantation 1992; 54: 710.
18. Mackenzie HS, Troy JL, Rennke HG, Brenner BM. TCV 116 prevents progressive renal injury in rats with extensive renal mass ablation. J Hypertens 1994; 12 (suppl 9): S11.
19. Rennke HS. Pathogenesis and significance of non-primary focal and segmental glomerulosclerosis. Am J Kidney Dis 1089; 13: 443.
20. Tamatani T, Miyasaka M. Identification of monoclonal antibodies reactive with the rat homolog of ICAM-1, and evidence for a differential involvement of ICAM-1 in the adherence of resting versus activated lymphocytes to high endothelial cells. Int Immunol 1990; 2: 165.
21. Platzer C, Ode HS, Reinke P, Docke WD, Ewert R, Volk HD. Quantitative PCR analysis of cytokine transcription patterns in peripheral mononuclear cells after anti-CD3 rejection therapy using two novel multi-specific competitor fragments. Transplantation 1994; 58: 264.
22. Volk HD, Muller S, Yarkoni S, Diamantstein T, Lorberboum GH. Mechanisms of dichotomous action of IL-2-Pseudomonas exotoxin 40 (IL-2-PE40) on cell-mediated and humoral immune response. J Immunol 1994; 153: 2497.
23. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156.
24. Nadeau KC, Azuma H, Tilney NL. Sequential cytokine dynamics in chronic rejection of rat renal allografts: roles for cytokines RANTES and MCP-1. Proc Natl Acad Sci USA 1995; 92: 8729.
25. Takada M, Nadeau KC, Shaw GD, Tilney NL. Early cellular and molecular changes in ischemia/reperfusion injury: inhibition by a selectin antagonist, P-selectin glycoprotein ligand-1. Transplant Proc 1997; 29: 1324.